purebiologics.com Open in urlscan Pro
94.152.195.120  Public Scan

Form analysis
1 forms found in the DOM

https://purebiologics.com

<form action="https://purebiologics.com">
  <div class="searchbox">
    <div class="searchbox__title"> Search </div>
    <div class="searchbox__input">
      <input type="text" name="s" placeholder="Enter the search term">
      <button type="submit"><svg width="16px" height="16px" viewBox="0 0 16 16" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
          <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
            <g fill="#001021" fill-rule="nonzero">
              <g transform="translate(-0.000000, 0.000000)">
                <path
                  d="M5.2734375,1.8375 C7.7234375,-0.6125 11.7109375,-0.6125 14.1609375,1.8375 C15.3484375,3.025 16.0015625,4.6 16.0015625,6.278125 C16.0015625,7.95625 15.3484375,9.534375 14.1609375,10.721875 C12.9359375,11.946875 11.3265625,12.559375 9.7171875,12.559375 C8.3546875,12.559375 6.9921875,12.121875 5.8609375,11.24375 L5.8609375,11.24375 L1.3359375,15.76875 C1.1828125,15.921875 0.9828125,15.996875 0.7828125,15.996875 C0.5828125,15.996875 0.3828125,15.921875 0.2296875,15.76875 C-0.0765625,15.4625 -0.0765625,14.96875 0.2296875,14.6625 L0.2296875,14.6625 L4.7546875,10.140625 C3.8984375,9.040625 3.4328125,7.696875 3.4328125,6.28125 C3.4328125,4.603125 4.0859375,3.025 5.2734375,1.8375 Z M9.7140625,1.5625 C8.5078125,1.5625 7.2984375,2.021875 6.3765625,2.94375 C5.4828125,3.834375 4.9921875,5.021875 4.9921875,6.28125 C4.9921875,7.540625 5.4859375,8.728125 6.3765625,9.61875 C8.2171875,11.459375 11.2140625,11.459375 13.0546875,9.61875 C13.9484375,8.725 14.4390625,7.540625 14.4359523,6.28125 C14.4359523,5.021875 13.9421875,3.834375 13.0515625,2.94375 C12.1328125,2.021875 10.9234375,1.5625 9.7140625,1.5625 Z">
                </path>
              </g>
            </g>
          </g>
        </svg></button>
    </div>
    <div class="searchbox__close">
      <div class="box">
        <div class="box__icon">
          <span></span>
          <span></span>
        </div>
        <div class="box__text">Close</div>
      </div>
    </div>
  </div>
</form>

Text Content

Search

Close
 * About us
   * Our team
   * Science at Pure Biologics
   * History
   * Development strategy
 * Therapeutic portfolio
   * Immunooncology
   * Non-systemic therapies
 * Contract research
 * Investors & media
   * Current reports (PL)
   * Periodic reports (PL)
   * General meetings (PL)
   * Prospectus (PL)
 * News
 * Careers
 * Contact


 * EN
   * PL




HARNESSING THE POWER
OF ANTIBODIES AND APTAMERS


Therapeutic portfolio





WEBINAR WITH THE MANAGEMENT BOARD ORGANIZED BY “STREFA INWESTOROW”


INITIATION OF THE IN VIVO STAGE IN THE PB003


PURE BIOLOGICS OPTIMIZES THE PB004 PLAN TO OBTAIN RELEVANT CLINICAL DATA FASTER


PURE BIOLOGICS EXTENDS THE PATENT PROTECTION OF THE PUREAPTA PLATFORM


SUCCESSFUL APTAMER SELECTION RESEARCH CONTRACT


WEBINAR WITH THE MANAGEMENT BOARD ORGANIZED BY “STREFA INWESTOROW”


INITIATION OF THE IN VIVO STAGE IN THE PB003


PURE BIOLOGICS OPTIMIZES THE PB004 PLAN TO OBTAIN RELEVANT CLINICAL DATA FASTER


PURE BIOLOGICS EXTENDS THE PATENT PROTECTION OF THE PUREAPTA PLATFORM


SUCCESSFUL APTAMER SELECTION RESEARCH CONTRACT


WEBINAR WITH THE MANAGEMENT BOARD ORGANIZED BY “STREFA INWESTOROW”


INITIATION OF THE IN VIVO STAGE IN THE PB003


PURE BIOLOGICS OPTIMIZES THE PB004 PLAN TO OBTAIN RELEVANT CLINICAL DATA FASTER


PURE BIOLOGICS EXTENDS THE PATENT PROTECTION OF THE PUREAPTA PLATFORM


SUCCESSFUL APTAMER SELECTION RESEARCH CONTRACT




THERAPEUTIC PORTFOLIO



Pure Biologics’ therapeutic portfolio includes new immunooncology therapies and
non-systemic treatment of autoimmune, neurodegenerative and rare diseases. It is
a total of a dozen projects, including five key projects in which we use
antibody and aptamer technologies to develop molecules with therapeutic
potential.


More



CONTRACT RESEARCH



Pure Biologics engages in commercial collaboration, offering contract research
covering three main specialties – aptamers, antibodies and proteins. Our
solutions combine a team of highly qualified scientists, the potential of our
technology platforms and many years of operational experience.


More



INVESTORS & MEDIA



Pure Biologics is the first entity in Poland to focus on development of
completely new, not generic or biosimilar, biological drugs based on antibodies
and therapeutic aptamers. This is a challenge that is currently a leading trend
in the global pharmaceutical industry.


More




CONTACT

info@purebiologics.com
Secretariat & Administration
+48 795 611 811

Pure Biologics SA
Duńska 11
54-427 Wroclaw, Poland

 * REGON: 021305772
 * VAT: PL8943003192
 * KRS: 0000712811


JOIN US

 * 
 * 
 * 
 * 


Copyright © 2020 Pure Biologics
 * Privacy Policy
 * Cookie policy
 * Site map

Cheers to digital products - mohi.to
 * About us Icon/Scroll
   * Our team
   * Science at Pure Biologics
   * History
   * Development strategy
 * Therapeutic portfolio Icon/Scroll
   * Immunooncology
   * Non-systemic therapies
 * Contract research
 * Investors & media Icon/Scroll
   * Current reports (PL)
   * Periodic reports (PL)
   * General meetings (PL)
   * Prospectus (PL)
 * News
 * Careers
 * Contact

 * EN
   * PL

Menu Close


We use cookies to give you the best browsing experience, site traffic analysis,
and advertisement management.


Pure Biologics - Harnessing the power of antibodies and aptamers